STADA UK HOLDINGS LTD.

Active Huddersfield

Wholesale of pharmaceutical goods

1 employees website.com
Wholesale of pharmaceutical goods
S

STADA UK HOLDINGS LTD.

Wholesale of pharmaceutical goods

Founded 5 Aug 2013 Active Huddersfield, United Kingdom 1 employees website.com
Wholesale of pharmaceutical goods
Accounts Submitted 19 Aug 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 26 Aug 2025 Next due 19 Aug 2026 3 months remaining
Net assets £183M £20M 2024 year on year
Total assets £504M £62M 2024 year on year
Total Liabilities £321M £42M 2024 year on year
Charges 8
8 outstanding

Contact & Details

Contact

Registered Address

The Globe Third Floor, Bridge Street Slaithwaite Huddersfield HD7 5JN United Kingdom

Full company profile for STADA UK HOLDINGS LTD. (08637720), an active company based in Huddersfield, United Kingdom. Incorporated 5 Aug 2013. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2013–2024)

Cash in Bank

£337.65k

Increased by £28.18k (+9%)

Net Assets

£182.52M

Increased by £20.18M (+12%)

Total Liabilities

£321.05M

Increased by £41.95M (+15%)

Turnover

N/A

Employees

1

Decreased by 1 (-50%)

Debt Ratio

64%

Increased by 1 (+2%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Frank SeilerDirectorGermanGermany575 Aug 2013Active

Shareholders

Shareholders (1)

Stada Arzneimittel Aktiengesellschaft
100.0%

Persons with Significant Control

Persons with Significant Control (3)

3 Active 1 Ceased

Stada Arzneimittel Aktiengesellschaft

Germany

Active
Notified 5 Aug 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Cinven Partnership Llp

Unknown

Active
Notified 14 Oct 2021
Nature of Control
  • Significant Influence Or Control

Capvest Partners Llp

Unknown

Active
Notified 31 Mar 2026
Nature of Control
  • Significant Influence Or Control

Cinven Partnership Llp

Ceased 31 Mar 2026

Ceased

Group Structure

Group Structure

STADA UK HOLDINGS LTD. Current Company

Charges

Charges

8 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
1 May 2026Persons With Significant ControlCapvest Partners Llp notified as a person with significant control
1 May 2026Persons With Significant ControlCessation of Cinven Partnership Llp as a person with significant control on 31 Mar 2026
5 Nov 2025OfficersAppointment of Mr Craig Richard Shaw as director on 3 Nov 2025
4 Nov 2025OfficersTermination of Volker Sydow as director on 3 Nov 2025
6 Oct 2025Persons With Significant ControlWithdrawal Of A Person With Significant Control Statement
1 May 2026 Persons With Significant Control

Capvest Partners Llp notified as a person with significant control

1 May 2026 Persons With Significant Control

Cessation of Cinven Partnership Llp as a person with significant control on 31 Mar 2026

5 Nov 2025 Officers

Appointment of Mr Craig Richard Shaw as director on 3 Nov 2025

4 Nov 2025 Officers

Termination of Volker Sydow as director on 3 Nov 2025

6 Oct 2025 Persons With Significant Control

Withdrawal Of A Person With Significant Control Statement

Recent Activity

Latest Activity

Capvest Partners Llp notified as a person with significant control

1 weeks ago on 1 May 2026

Cessation of Cinven Partnership Llp as a person with significant control on 31 Mar 2026

1 weeks ago on 1 May 2026

Appointment of Mr Craig Richard Shaw as director on 3 Nov 2025

6 months ago on 5 Nov 2025

Termination of Volker Sydow as director on 3 Nov 2025

6 months ago on 4 Nov 2025

Withdrawal Of A Person With Significant Control Statement

7 months ago on 6 Oct 2025